HerbertCWhinnaMD
Pathology • Chapel Hill, NCClinical Pathology, Clinical Informatics
Associate Professor, Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Whinna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
University of WashingtonResidency, Pathology-Anatomic and Clinical, 1994 - 1997
University of North Carolina at Chapel Hill School of MedicineClass of 1994
Certifications & Licensure
NC State Medical License 1999 - 2025- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 139 citationsCoagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.Kenneth I. Ataga, Charity G. Moore, Cheryl A. Hillery, Susan Jones, Herbert C. Whinna
Haematologica. 2008-01-01 - 27 citationsRNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpinsMartha L Jeter, Linda V Ly, Yolanda M. Fortenberry, Herbert C. Whinna, Rebekah R. White
FEBS Letters. 2004-06-18 - 85 citationsInteraction of heparin cofactor II with biglycan and decorin.Herbert C. Whinna, Haing U. Choi, Lawrence C. Rosenberg, Frank C. Church
The Journal of Biological Chemistry. 1993-02-25
Press Mentions
Benefits and Bumps of Shifting to BeakerNovember 20th, 2017
Grant Support
- Glycosylphosphatidylinositol (GPI) Anchored AntithrombinNational Heart, Lung, And Blood Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
